Natural Killer Cells Therapeutics Market Growth and Restrain Factors Analysis Report In The Latest Research

The global market for NK Cell Therapeutics was valued at $1.40 billion in 2018 and is forecasted to reach $5.09 billion by 2026, with a notable CAGR of 17.4% during the period of 2019-2026.

𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-sample/2132

Factors such as the increasing use of NK cells for treating infections and liver diseases, growing awareness among the population regarding various immunotherapies, and the rise in R&D for developing bi-specific antibodies to engage NK cells in eliminating tumor cells are driving the market growth. However, challenges such as the lack of specificity and poor in-vivo survival of cells, high therapy costs, and adverse side effects are restraining the market's growth. Despite these challenges, significant R&D activities towards immunotherapy development in emerging economies are expected to create lucrative opportunities in the near future.

Download Sample Report: Link

In terms of therapeutics, the segment of NK cell-directed antibodies held the majority share in 2018, accounting for nearly three-fifths of the total market share. This segment is expected to maintain its dominance during the forecast period, driven by the increased use of monoclonal antibodies for various disease treatments. Additionally, the NK cell therapies segment is projected to witness the fastest growth, with a CAGR of 17.6% until 2026, propelled by extensive research aimed at developing NK cell therapeutics for cancer treatment.

The cancer segment dominated the market based on application, contributing to more than three-fourths of the total market revenue in 2018. This dominance is expected to continue through 2019-2026 due to a significant increase in cancer prevalence. Conversely, the gastrointestinal diseases segment is anticipated to grow at the fastest CAGR of 19.3% during the forecast period, attributed to the growing geriatric population and improvements in healthcare facilities.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/2132

North America held the largest share of the market in 2018, accounting for nearly half of the total market, primarily due to the rising incidence of cancer in the region. On the other hand, the Asia-Pacific region is expected to exhibit the fastest CAGR of 19.5% throughout the study period.

Key players in the market include Affimed N.V., Altor BioScience Corporation, Chipscreen Biosciences Ltd., NKT Therapeutics Inc., Innate Pharma S.A., Sorrento Therapeutics Inc., NantKwest Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company Limited, among others. These players have implemented various high-end strategies such as expansions, mergers & acquisitions, partnerships, joint ventures, and collaborations to strengthen their position in the industry.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Medical Device Packaging Market https://www.alliedmarketresearch.com/medical-device-packaging-market

Acupuncture Needles Market https://www.alliedmarketresearch.com/acupuncture-needles-market

Veterinary Medicine Market https://www.alliedmarketresearch.com/veterinary-medicine-market

Implantable Insulin Pump Market https://www.alliedmarketresearch.com/implantable-insulin-pump-market

Contact Us:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.